The present disclosure provides for engineered chromodomains for enhanced binding affinity to methylated proteins, their use in screening, gene transcription regulation, and in methods of their administration. The compositions and methods provided herein can be used for targeting protein methylation as a means for identifying markers of pathology for diagnostic or therapeutic applications.